PeptiDream Inc. (4587) Earnings Releases & Disclosures
| Date | Type | Title | Files |
|---|---|---|---|
| 2026-11-11 | Earnings Release | Consolidated Financial Results for the Nine Months Ended September 30, 2026 [IFRS] | |
| 2026-11-05 | — | PeptiDream Announces Initiation of Phase 1 Clinical Trial by MSD | |
| 2026-10-07 | — | PeptiDream Announces Achievement of Development Milestone in Collaboration with MSD | |
| 2026-08-12 | Earnings Release | Consolidated Financial Results for the Six Months Ended June 30, 2026 [IFRS] | |
| 2026-08-12 | — | Initiation of Phase 1 Clinical Trial by Novartis Marks Milestone for PeptiDream |
TDnet keeps only 31 days; this site accumulates daily and cannot backfill earlier disclosures.